Dr. Pragati Katiyar leads the NIA portfolio analysis and evaluation projects and responds to NIA and NIH leadership inquiries. She had previously worked in the “Ras Initiative” at the National Cancer Institute and as a Scientific Program Manager in the AIDS program at the National Health Lung Blood Institute.
Dr. Katiyar had received her Ph.D. in Tumor Biology from the Lombardi Cancer Center at Georgetown University, Washington, DC where she had investigated molecular mechanisms involved in the BRCA1 (tumor suppressor) inhibition of progesterone receptor signaling to prevent breast cancer. She completed her postdoctoral work at the Thomas Jefferson University, where she studied molecular mechanisms involved in the migration and invasion of melanoma cells. During her tenure at the Thomas Jefferson University, she served as a president of Jefferson Postdoctoral Association and had worked to enhance the first-hand experience of international fellows entering the country for the first time. At the same time, she had also written articles on various career development options available beyond academia for the postdoctoral fellows trying to transition to a non-academic career.